New real-world data suggest early lactate clearance can predict massive transfusion needs in upper gastrointestinal bleeding, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced presentations of data from its IMerge Phase 3 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results